Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06419530

A Study on Probiotic Formula in Autistic Children

A Double-blind Randomized Clinical Trail Study on the Effectiveness and Safety of Probiotic Formula in Autistic Children With Gastrointestinal Symptoms

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Third Military Medical University · Academic / Other
Sex
All
Age
3 Years – 14 Years
Healthy volunteers
Not accepted

Summary

A Randomized controlled double-blind clinical study on the effectiveness and safety of probiotic formula in Autistic children with gastrointestinal symptoms.

Detailed description

Autism spectrum disorder (ASD) is a neurodevelopmental disorder of children with estimated prevalence of near 1% by WHO in 2022. To date, the cause and etiology of ASD is still unknown, and there is no proven effective pharmacological treatment for ASD. The gut microbiota has been proved to have great impact on neurological development, in this study, we aim to explore the effectiveness of safety of probiotic formula on ASD children, by comparing with placebo and fecal microbiota transplantation (FMT). This study will be a randomized, double-blind, placebo-controlled trial. Totally, 156 Autistic children with gastrointestinal symptoms will be enrolled and randomly allocated into three groups: probiotic formula group, fecal microbiota transplantation (FMT) group and placebo group. participants are treated with 4 probiotic formula/FMT/placebo capsules each day, for 84 days. Participants would be followed up at the 4th, 8th, 12th and 24th week after enrollment by simple physical examination, relevant scale questionaire (including Autism Behavior Checklist(ABC),Childhood Autism Rating Scale(CARS),Gastrointestinal Symptom Rating Scale(GSRS),Social Responsiveness Scale(SRS),Self-Rating Anxiety Scale(SAS) and Autism Diagnostic Observation Schedule(ADOS)), and blood and fecal samples collection.

Conditions

Interventions

TypeNameDescription
OTHERProbiotic formula capsuleThe subjects take 4 capsules a day for 84 days.
OTHERplacebo capsuleThe subjects take 4 capsules a day for 84 days.
OTHERFMT capsuleThe subjects take 4 capsules a day for 84 days.

Timeline

Start date
2024-06-01
Primary completion
2027-06-01
Completion
2028-06-01
First posted
2024-05-17
Last updated
2024-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06419530. Inclusion in this directory is not an endorsement.

A Study on Probiotic Formula in Autistic Children (NCT06419530) · Clinical Trials Directory